Want to see TSE:BPC full AI Analyst Report?
Top Page
Pangea Natural Food, Inc.
(BPC)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.42
▼(-16.00% Downside)
Action:Reiterated
Date:08/25/26
The score is primarily constrained by weak financial performance—severe losses, negative margins, and persistent (accelerating) cash burn alongside equity instability. Technicals add modest pressure with a below-moving-average downtrend and negative MACD, partially offset by near-term oversold signals. Corporate updates are positive but early-stage, and valuation is difficult to support given negative earnings and no dividend yield provided.
Positive Factors
Low Financial Leverage
Minimal debt reduces interest obligations and refinancing exposure, giving the company greater flexibility to pursue operations or restructuring. This is a durable balance-sheet advantage, although it does not resolve the need to fund ongoing losses.
Negative Factors
Severely Negative Profitability
Deeply negative gross and net margins indicate that the current business model is not covering product costs or operating expenses. Without substantial pricing, sourcing, or mix improvements, revenue growth is unlikely to translate into durable earnings or self-funded expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Financial Leverage
Minimal debt reduces interest obligations and refinancing exposure, giving the company greater flexibility to pursue operations or restructuring. This is a durable balance-sheet advantage, although it does not resolve the need to fund ongoing losses.
Read all positive factors
Pangea Natural Food, Inc. (BPC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$20.78M
Dividend YieldN/A
Average Volume (3M)153.06K
Price to Earnings (P/E)―
Beta (1Y)0.19
Revenue Growth10003.80%
EPS Growth-65.30%
CountryCA
Employees2
SectorConsumer Defensive
Sector Strength42
IndustryRestaurants
Share Statistics
EPS (TTM)-0.19
Shares Outstanding47,231,210
10 Day Avg. Volume179,826
30 Day Avg. Volume153,063
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)10.48
Price to Sales (P/S)196.00
P/FCF Ratio-4.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pangea Natural Food, Inc. Business Overview & Revenue Model
Company Description
The Precision Peptide Company Inc. manufactures and distributes plant-based patties and other food products in Canada. The company offers old fashioned ghee; energy gel; and plant-based patty; energy gel products, and munchie mix, as well as custo...
Pangea Natural Food, Inc. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
10
Very Negative
| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 49.72K | 12.20K | 285.59K | 580.99K | 68.50K |
| Gross Profit | -69.17K | 6.91K | -32.79K | 40.97K | -67.25K |
| EBITDA | -2.16M | -917.21K | -1.64M | -855.30K | -172.28K |
| Net Income | -4.53M | -1.03M | -1.66M | -1.13M | -173.19K |
Balance Sheet | |||||
| Total Assets | 1.33M | 182.29K | 191.72K | 620.34K | 1.34M |
| Cash, Cash Equivalents and Short-Term Investments | 960.01K | 140.09K | 51.64K | 75.95K | 807.57K |
| Total Debt | 0.00 | 17.83K | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 401.26K | 732.74K | 330.00K | 408.57K | 116.82K |
| Stockholders Equity | 929.72K | -550.45K | -138.28K | 211.76K | 1.23M |
Cash Flow | |||||
| Free Cash Flow | -2.33M | -439.41K | -980.68K | -725.80K | -590.75K |
| Operating Cash Flow | -2.33M | -439.41K | -980.68K | -718.60K | -529.76K |
| Investing Cash Flow | -270.17K | 0.00 | 0.00 | -7.20K | -60.98K |
| Financing Cash Flow | 3.40M | 527.86K | 956.37K | -1.32K | 1.40M |
Pangea Natural Food, Inc. Technical Analysis
Negative
0.50
Price Trends
0.48
Negative
0.47
Negative
0.38
Positive
Market Momentum
>-0.01
Positive
45.43
Neutral
35.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BPC, the sentiment is Negative. The current price of 0.5 is above the 20-day moving average (MA) of 0.46, above the 50-day MA of 0.48, and above the 200-day MA of 0.38, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.43 is Neutral, neither overbought nor oversold. The STOCH value of 35.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:BPC.
Pangea Natural Food, Inc. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
43 Neutral | C$24.59M | -13.72 | 47.73% | ― | 32.91% | 55.73% | |
41 Neutral | C$20.78M | -2.81 | -241.90% | ― | 10003.80% | -65.30% | |
41 Neutral | C$441.11K | -0.67 | 31.16% | ― | -3.70% | 51.27% | |
25 Underperform | C$50.42M | -24.03 | 81.87% | ― | ― | ― |
* Consumer Defensive Sector Average
TSE:BPC
Pangea Natural Food, Inc.
0.45
0.13
40.63%
TSE:ISTK
Good Flour Corp
0.40
-1.46
-78.49%
TSE:BITE
Blender Bites
0.15
0.00
0.00%
TSE:MEAT
Modern Meat
0.06
-0.06
-50.00%
TSE:NPRA
Nepra Foods
0.16
0.07
82.35%
Pangea Natural Food, Inc. Corporate Events
Business Operations and StrategyProduct-Related Announcements
Precision Peptide Plans Needle-Free Tirzepatide Patch for Expanding GLP-1 Market
Positive
Aug 19, 2026
The Precision Peptide Company Inc. announced it is developing a tirzepatide-based transdermal patch in the U.S. as an addition to its peptide-focused product portfolio. The patch is designed to deliver the dual GIP/GLP-1 agonist through the skin, ...
Business Operations and StrategyProduct-Related Announcements
Precision Peptide Company Consolidates Amino Innovations Storefront Into Its Own Platform
Positive
Aug 7, 2026
The Precision Peptide Company has completed the migration of the Amino Innovations online supplement store, including its seven-product catalogue and existing customer base, onto its own e-commerce site. As a result, sales through the legacy Amino...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.